Literature DB >> 8690200

Effect of omeprazole on the distribution of metronidazole, amoxicillin, and clarithromycin in human gastric juice.

A F Goddard1, M J Jessa, D A Barrett, P N Shaw, J P Idström, C Cederberg, R C Spiller.   

Abstract

BACKGROUND & AIMS: The mechanism by which antimicrobial therapy against Helicobacter pylori is enhanced by acid suppression is unknown. The aim of this study was to investigate the effect of omeprazole on gastric juice, plasma, and saliva concentrations of metronidazole, amoxicillin, and clarithromycin.
METHODS: Single doses of antibiotic were administered intravenously to 24 healthy men (each antibiotic to 8 subjects) while taking placebo or omeprazole. Antibiotic concentrations were measured in gastric juice, plasma, and saliva. The pharmacokinetic parameters gastric clearance and gastric transfer fraction were calculated for each antibiotic.
RESULTS: In the omeprazole group compared with the placebo group, mean maximum antibiotic gastric juice concentrations (in milligram per liter) of metronidazole decreased from 33.6 to 8.3 (P = 0.0001), whereas those of clarithromycin were unchanged, and those of amoxicillin increased from 0.13 to 0.68 (P = 0.02). Omeprazole increased salivary concentrations of metronidazole (P = 0.02) but had no effect on clarithromycin concentrations (no amoxicillin was detectable in saliva).
CONCLUSIONS: Omeprazole decreases the intragastric concentrations of metronidazole by reducing acid secretion and increases intragastric concentrations of amoxicillin partly by reducing gastric juice volume. Novel pharmacokinetic parameters have been described that provide an insight into the mechanisms underlying drug transfer across the blood-stomach barrier.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8690200     DOI: 10.1053/gast.1996.v111.pm8690200

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  53 in total

1.  Local gastric and serum concentrations of rebamipide following oral ingestion in healthy volunteers.

Authors:  Taiji Akamatsu; Naoshi Nakamura; Naoyuki Furuya; Toshiki Shimizu; Akira Gotou; Kendo Kiyosawa; Tsutomu Katsuyama; Takahiko Osumi; Yukihiro Hirao; Gohatiro Miyamoto
Journal:  Dig Dis Sci       Date:  2002-06       Impact factor: 3.199

Review 2.  Eradication of Helicobacter pylori: a clinical update.

Authors:  Marco Romano; Antonio Cuomo
Journal:  MedGenMed       Date:  2004-02-17

3.  Influence of antisecretory drugs on Helicobacter pylori eradication rates.

Authors:  M Pellegrini; R Urso; G Giorgi; D Cerretani; R C Spiller; P Sherwood
Journal:  Gut       Date:  2004-11       Impact factor: 23.059

4.  Pharmacokinetic interactions between ilaprazole and clarithromycin following ilaprazole, clarithromycin and amoxicillin triple therapy.

Authors:  Shan Cao; Gan Zhou; Dong-sheng Ou-Yang; Hui-zi Wu; Kui Xiao; Yao Chen; Dong Guo; Lan Fan; Zhi-rong Tan; Hai-tang Hu; Xiang-hong Qin; Hong-hao Zhou; Wei Zhang
Journal:  Acta Pharmacol Sin       Date:  2012-07-23       Impact factor: 6.150

Review 5.  Pharmacokinetic considerations in the eradication of Helicobacter pylori.

Authors:  U Klotz
Journal:  Clin Pharmacokinet       Date:  2000-03       Impact factor: 6.447

6.  In vitro assessment of gastric mucosal transfer of anti-Helicobacter therapeutic agents.

Authors:  A F Goddard; R C Spiller
Journal:  Antimicrob Agents Chemother       Date:  1997-06       Impact factor: 5.191

7.  Impact of acid secretion, gastritis, and mucus thickness on gastric transfer of antibiotics in rats.

Authors:  P V Sherwood; J I D Wibawa; J C Atherton; N Jordan; D Jenkins; D A Barrett; P N Shaw; R C Spiller
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

Review 8.  Basis for the management of drug-resistant Helicobacter pylori infection.

Authors:  Francis Mégraud
Journal:  Drugs       Date:  2004       Impact factor: 9.546

9.  Nitazoxanide, a potential drug for eradication of Helicobacter pylori with no cross-resistance to metronidazole.

Authors:  F Mégraud; A Occhialini; J F Rossignol
Journal:  Antimicrob Agents Chemother       Date:  1998-11       Impact factor: 5.191

Review 10.  Diagnostic methods for Helicobacter pylori detection and eradication.

Authors:  A F Goddard; R P H Logan
Journal:  Br J Clin Pharmacol       Date:  2003-09       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.